Literature DB >> 7600826

Frequency of bacteremia associated with transesophageal echocardiography in intensive care unit patients: a prospective study of 139 patients.

H Mentec1, P Vignon, S Terré, B Cholley, E Roupie, P Legrand, F Lemaire, C Brun-Buisson.   

Abstract

OBJECTIVE: To determine the occurrence rate of bacteremia associated with transesophageal echocardiography in intensive care unit (ICU) patients.
DESIGN: A prospective study of 139 patients undergoing transesophageal echocardiography.
SETTING: The medical ICU of a tertiary referral teaching hospital. PATIENTS: One hundred thirty-nine ICU patients (mean age 58 yrs) who underwent transesophageal echocardiography.
INTERVENTIONS: Blood samples were systematically drawn for aerobic and anaerobic culture at the following times: before (blood culture 1), at the end of (blood culture 2), and 30 mins after (blood culture 3) transesophageal echocardiography examinations.
MEASUREMENTS AND MAIN RESULTS: The mean duration of transesophageal echocardiography was 35 mins (range 7 to 120). One hundred thirty-four patients received mechanical ventilation; 125 patients had a nasogastric tube. Fifty-one patients had one or more underlying conditions that usually justify antimicrobial prophylaxis of bacterial endocarditis before high-risk procedures. Fifty-six patients did not receive any antibiotic treatment at the time of transesophageal echocardiography. In 114 patients, the three blood cultures were negative. In six patients, transesophageal echocardiography was performed during a preexisting bacteremia. A contamination (only one positive blood culture of the three sampling times) with coagulase-negative staphylococci occurred in four patients at blood culture 1, five patients at blood culture 2, and six patients at blood culture 3. Contamination with Corynebacterium species occurred in two patients at blood culture 2. In one patient receiving cefotaxime and netilmicin, blood culture 1 was sterile and blood cultures 2 and 3 yielded coagulase-negative staphylococci. In one patient receiving no antibiotic treatment, blood culture 1 was sterile and blood cultures 2 and 3 yielded Enterococcus faecalis. None of these two patients received a specific antibiotic treatment or developed any secondary septic focus.
CONCLUSIONS: The overall frequency of bacteremia induced by transesophageal echocardiography in ICU patients was 1.4% (two of 139 patients) (95% confidence interval 0.2% to 5.1%). The frequency did not differ whether patients received antibiotics before transesophageal echocardiography (one [1.2%] of 83 patients) or not (one [1.8%] of 56 patients) (p = .96). Therefore, routine antimicrobial prophylaxis does not appear justified before transesophageal echocardiography in ICU patients.

Entities:  

Mesh:

Year:  1995        PMID: 7600826     DOI: 10.1097/00003246-199507000-00007

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Is antibiotic prophylaxis ever necessary before transoesophageal echocardiography?

Authors:  J B Chambers; J L Klein; S R Bennett; M J Monaghan; J C Roxburgh
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

2.  Bacteraemia following single-stage percutaneous dilatational tracheostomy.

Authors:  A G Saayman; G P Findlay; R A Barnes; M P Wise
Journal:  Intensive Care Med       Date:  2009-07-31       Impact factor: 17.440

3.  Transesophageal echocardiography-associated tracheal microaspiration and ventilator-associated pneumonia in intubated critically ill patients: a multicenter prospective observational study.

Authors:  François Bagate; Anahita Rouzé; Farid Zerimech; Florence Boissier; Vincent Labbe; Keyvan Razazi; Guillaume Carteaux; Nicolas de Prost; Malika Balduyck; Patrice Maboudou; Saad Nseir; Armand Mekontso Dessap
Journal:  Crit Care       Date:  2020-12-07       Impact factor: 9.097

Review 4.  Hemodynamic monitoring using trans esophageal echocardiography in patients with shock.

Authors:  Florence Boissier; François Bagate; Armand Mekontso Dessap
Journal:  Ann Transl Med       Date:  2020-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.